|
|
Article: FDA Bolsters Generic Drug Supervision;Fraud Has Tarnished Agency's Credibility
- Article from:
- The Washington Post
- Article date:
- August 19, 1989
- Author:
CopyrightThis material is published under license from the Washington Post. All inquiries regarding rights should be directed to the Washington Post. (Hide copyright information)
|
The Food and Drug Administration, reeling from reports of
corruption and fraud in the generic drug industry and in its own
regulation of that industry, yesterday announced sweeping
institutional changes designed to the restore the agency's
credibility and shore up its enforcement and oversight authority.
In a statement with Health and Human Services Secretary Louis W.
Sullivan, FDA Commissioner Frank E. Young announced plans for
"intensified surveillance" of firms making generic drugs and the
creation of an FDA ombudsman to "ensure fairness in the process of
applications from industry." Young confirmed a controversial new
arrangement whereby the agency will cede part of its enforcement ...